Blog

Shares of leading water solutions provider Badger Meter (NYSE: BMI) plunged 9% as of 12:30 p.m. ET Thursday, according to data provided by S&P Global Market Intelligence.

This drop comes in spite of

Shares of Lucid Group (NASDAQ: LCID) shifted into reverse Thursday after the electric vehicle (EV) maker announced a secondary stock offering and released disappointing preliminary results for the

Image source: The Motley Fool.

Elevance Health (NYSE: ELV)Q3 2024 Earnings CallOct 17, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

Marsh & McLennan Companies (NYSE: MMC)Q3 2024 Earnings CallOct 17, 2024, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

ASML's (NASDAQ: ASML) stock plummeted 16% on Oct. 15 after it accidentally posted its third-quarter earnings report a day ahead of schedule, and the numbers weren't impressive.

The Dutch

Very few public companies offer monthly dividends, and the ones that do are typically real estate investment trusts (REITs) because they are legally required to pay out 90% of their taxable earnings

Billionaire investor Philippe Laffont is the founder of Coatue Management, one of Wall Street's most prestigious hedge funds. Below, I'm going to explore some of the more interesting moves Coatue

In today's video, I discuss Taiwan Semiconductor Manufacturing (NYSE: TSM) and why Nvidia (NASDAQ: NVDA) stock investors should pay attention. To learn more, check out the short video, consider

Buying and holding stocks is easier said than done. Ideally, you find a great company, buy the stock, and let it grow and pay you dividends forever. The problem is that few companies fit that bill

Once a company's shares rise rapidly, investors might wonder if it's still worth investing in the stock. The answer is that it depends. Some companies' strong performances are short-lived. Others

Celsius Holdings (NASDAQ: CELH) has been a terrific growth stock to own over the past decade as both its top and bottom lines have soared. But this year has been a nightmare for shareholders of the

Small biotech companies sometimes see their shares skyrocket because of clinical or regulatory progress. That happened this year to Viking Therapeutics and Summit Therapeutics, which gained

With interest rates likely headed lower over the next few years as the Fed embarks on a rate-cutting cycle, income-oriented investors may be looking for places to invest that can offer higher yields

If your priority is to receive a stable and recurring dividend, a good idea is to focus on businesses that aren't trying to do too much. When a company tries to grow its business while also paying a

Last Friday, you could almost hear a collective sigh of relief from the stock market and from economists after JPMorgan Chase (NYSE: JPM) published its third-quarter results. The company is the

Medicare Part D plans save seniors a lot of money on retirement healthcare costs compared to paying for their prescriptions completely out of pocket, but they come with plenty of costs of their own

Nvidia (NASDAQ: NVDA) has been a pretty sure bet for investors over the past few years. The artificial intelligence (AI) chip giant has delivered triple-digit gains in earnings quarter after

ASML (NASDAQ: ASML) stock is falling after reporting quarterly financial results that disappointed stock market investors.

*Stock prices used were the afternoon prices of Oct. 14, 2024. The video

Berkshire Hathaway (NYSE: BRK.B) (NYSE: BRK.A) stock has long been popular with individual investors as it lets them ride along with one of the most successful investors of all time, Warren Buffett

Over the last couple of years, pharmaceutical giant Eli Lilly (NYSE: LLY) has made a splash in the red-hot weight loss space. The company's path-breaking innovation in using glucagon-like peptide-1

There are $200 billion reasons healthcare companies want to produce GLP-1 weight loss drugs. At that size, the market potential is huge, and the opportunities for revenue growth are plentiful.

But

Shares of pharmaceutical upstart Viking Therapeutics (NASDAQ: VKTX) have been soaring this year thanks to high hopes for VK2735, its promising GLP-1 weight loss treatment. Although the company

Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), the parent company of Google, is getting absolutely no love from the public markets right now. In fact, from a valuation standpoint, it's actually cheaper

Equities are still in a bull run. The S&P 500 is up by 22% so far in 2024. Not every company has come along for the ride, though. Exact Sciences (NASDAQ: EXAS), a cancer-focused biotechnology

Finding attractive dividend yields while the S&P 500 index is offering a scant 1.2% yield is pretty hard, but it isn't impossible. One area to look at is real estate investment trusts (REITs), which